Accumulation of fat molecules is detrimental to the cell. Researchers from the Yong Loo Lin School of Medicine, National ...
BIIB143, also known as cemdomespib, was the most advanced asset to get the chop. Biogen acquired the Hsp90 modulator in 2023 through its buyout of Reata, a deal that centered on the FDA-approved ...
Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...
The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in ...
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...
Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...
This research on TCE shows neurodegenerative diseases like Parkinson’s Disease aren’t all about your genes. Your environment ...
Enter SynPull, a new synaptosome imaging method developed by David Klenerman, John Danial, and colleagues at the University of Cambridge, England. SynPull combines single-molecule pull-down of ...
According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback